Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

DAIICHI SANKYO, INC.

Filed by MARSHALL & POPP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-03 06:26:12 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
1e8d3d96-5947-41fa-a5bf-06e8988bcc05
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Issues related to tariff and trade policy.

PHA · Pharmacy

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.